Covidien, a subsidiary of Medtronic Plc, has agreed to an undisclosed amount to settle some of the more than 11,000 lawsuits alleging the company’s transvaginal mesh device caused severe and painful injuries. The confidential agreement did not disclose how many lawsuits would be resolved. The company recorded a pre-tax charge of $180 million for the third quarter of 2014 to cover legal fees involving its transvaginal mesh. Medtronic acquired Covidien last year for $42.9 billion in cash and stocks. Transvaginal mesh is a type of surgical mesh used to treat common pelvic floor disorders such as stress urinary incontinence and ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.